Clinical Trial Update: DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS

View source ↗

Summary

A completed clinical trial examined screening for diamine oxidase (DAO) deficiency among patients with insomnia symptoms. The study was sponsored by AB Biotek.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Insomnia Disorder

Snippet

Sponsor: AB Biotek | Conditions: Insomnia, Insomnia Disorder | Status: COMPLETED